Kate Therapeutics reported raising $21.8 Million in an initial SEC Form D filing, from an offering of $23.4 Million
PRIVATEAug 07, 2024$21.8M of $23.4M raised
Amount Raised
$21.8 Million
$21.8 Million sold, per SEC Form D (first sale May 17, 2024)
Round Type
Venture
San DiegoBiotechnologyHealth CareGeneticsTherapeutics
Quick answer
Kate Therapeutics raised $21.8 Million in a funding round, dated May 17, 2024. Kate Therapeutics is based in San Diego, California, United States.
How much did Kate Therapeutics raise?
Kate Therapeutics raised $21.8 Million in a funding round on May 17, 2024.
What does Kate Therapeutics do?
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases.
Where is Kate Therapeutics based and how big is it?
Kate Therapeutics is based in San Diego, California, United States.
Who are the decision-makers at Kate Therapeutics?
Fundz holds 1 contact at Kate Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Kate Therapeutics, and when
A new round usually means Kate Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Kate Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Kate Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kate Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Kate Therapeutics
Location
San Diego, California, United States
About
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies. For more information, please visit KateTx's website at https://www.katetherapeutics.com/.
SOURCE Kate Therapeutics
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kate Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.